TGFB1 and cancer: Additionally, TGF-β–mediated enrichment of LncROR in exosomes increases CD133+ cancer stem cell populations and inhibits p53-dependent cell death, propagating a stem-like, chemoresistant phenotype throughout the tumor microenvironment [90, 92].